insomnia
Conditions
Interventions
Experimental group:Dexmedetomidine hydrochloride nasal spray combined with stellate ganglion block
Sponsors
The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.People who meet the diagnostic criteria for insomnia disorder; 2.Age 18 ~80 years old; 3.Sign an informed consent form with the patient or his/her family;
Exclusion criteria
Exclusion criteria: 1.Allergy to drugs (dexmedetomidine hydrochloride nasal spray, local anaesthetics etc.); 2.Recent history of myocardial infarction, asthma, glaucoma, goiter, abnormal conduction of cardiac excitation, Chronic obstructive pulmonary disease, liver, kidney, lung and other organs with serious lesions. 3.Combination of consciousness disorder, cognitive dysfunction, acute and chronic pain; 4.Poor compliance, unable to complete the content of the study and information collection; 5.Abnormal coagulation function, infection at the puncture site;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Neuroticism-Extroversion-Openness Personality Inventory;Hamilton depression scale;Hamilton anxiety scale;Psychomotor vigilance task;N-back;Mental resilience scale;Positive and negative affact schedule;Cortisol test;Patients' bedtime, sleeping time, waking time, waking time, daytime sleeping time, daytime sleeping;Incidence of adverse reactions;EEG, MRI; | — |
Countries
China
Contacts
Public ContactZhang Xinjian
The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed